A triple negative breast cancer study [28] showed that the majority of tumors (72.1%) are p-mTOR positive, whereas expression of p-mTOR is notcorrelated with tumor grade, lymph node status, and stage. Here, MTOR is linked to triple-negative breast carcinoma.